FDA Approvals in Oncology: July-September 2023
FDA approvals issued in third quarter 2023 included a new treatment for prostate cancer harboring BRCA mutations, two new...
FDA approvals issued in third quarter 2023 included a new treatment for prostate cancer harboring BRCA mutations, two new...
Based on estimates from the National Cancer Institute, in 2023, more than 110,000 cases of gynecologic cancers are expected...
As you say farewell to summer, say hello to the latest installment of Editors’ Picks selected by the editors...
In the span of a decade, the idea that tumor-derived molecules circulating in the bloodstream and other body fluids...
Bacteria account for over 75% of the Earth’s population. And while we often think of these microbes as something...
It sounds like something out of Frankenstein, but a new study in the AACR journal Cancer Discovery suggests that...
Across the surfaces of your mouth, throat, and nasal sinuses, layers of flat cells called squamous cells protect the...
Improved patient outcomes come from new treatments. New treatments stem from successful clinical trials. Clinical trials build on discoveries...
Guest Post by William G. Nelson, MD, PhD, Editor-in-Chief, Cancer Today The artificial intelligence (AI) revolution has important implications for...
Although not as common as breast, prostate, or lung cancer, kidney cancer is one of the most frequently diagnosed...